Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Liabilities and Shareholders Equity (2017 - 2025)

Akso Health (AHG) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $215.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Liabilities and Shareholders Equity rose 51.36% year-over-year to $215.0 million, compared with a TTM value of $440.2 million through Mar 2025, up 71.32%, and an annual FY2025 reading of $215.0 million, up 51.36% over the prior year.
  • Liabilities and Shareholders Equity was $215.0 million for Q1 2025 at Akso Health, up from $142.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $215.0 million in Q1 2025 and bottomed at $20.5 million in Q1 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $94.4 million, with a median of $62.8 million recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity tumbled 67.42% in 2023, then soared 594.12% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $31.7 million in 2021, then soared by 98.22% to $62.8 million in 2022, then crashed by 67.42% to $20.5 million in 2023, then skyrocketed by 594.12% to $142.0 million in 2024, then soared by 51.36% to $215.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for AHG at $215.0 million in Q1 2025, $142.0 million in Q1 2024, and $20.5 million in Q1 2023.